Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 10,010,878 $ 10,867,050
Accounts receivable 118,592 72,609
Prepaid expenses 1,111,318 784,920
Other current assets 716,910 447,566
Total Current Assets 11,957,698 12,172,145
Property and equipment, net 5,401,896 5,393,012
Operating lease right-of-use assets 593,108 619,392
Intangible assets, net 90,831 110,505
Total Assets 18,043,533 18,295,054
Current Liabilities    
Accounts payable 2,989,460 3,043,008
Accrued liabilities 2,719,182 2,872,247
Deferred revenue 10,000,000 10,000,000
Management and directors' fees payable 80,138 71,119
Current portion of long-term debt 1,121,069 1,066,700
Current portion of finance lease liabilities 46,917 46,014
Current portion of operating lease liabilities 238,764 245,163
Current portion of grant repayable 42,382 41,836
Total Current Liabilities 17,237,912 17,386,087
Long-term debt, net of current portion 2,549,116 2,779,240
Finance lease liabilities, net of current portion 429,977 436,132
Operating lease liabilities, net of current portion 381,722 400,091
Grant repayable, net of current portion 425,951 420,466
Total Liabilities 21,024,678 21,422,016
Stockholders' Equity (Deficit)    
Common Stock Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 63,111,766 shares and 57,873,379 shares, respectively 63,112 57,873
Additional paid-in capital 173,467,433 164,397,468
Accumulated other comprehensive income 170,619 227,097
Accumulated deficit (176,036,977) (167,257,429)
Total VolitionRx Limited Stockholders' Equity (Deficit) (2,335,813) (2,574,991)
Non-controlling interest (645,332) (551,971)
Total Stockholders' Equity (Deficit) (2,981,145) (3,126,962)
Total Liabilities and Stockholders' Equity (Deficit) $ 18,043,533 $ 18,295,054